Wave Life Sciences (WVE)

Wave Life Sciences Stock Analysis & Ratings

WVE Stock Chart & Stats

Day’s Range$1.18 - $1.24
52-Week Range$1.16 - $7.55
Previous Close$1.27
Average Volume (3M)385.69K
Market Cap$75.34M
P/E Ratio-0.5
Next EarningsAug 11, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score1
EPS (TTM)-2.37



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Wave Life Sciences’s price range in the past 12 months?
Wave Life Sciences lowest stock price was $1.16 and its highest was $7.55 in the past 12 months.
    What is Wave Life Sciences’s market cap?
    Wave Life Sciences’s market cap is $75.34M.
      What is Wave Life Sciences’s price target?
      The average price target for Wave Life Sciences is $7.00. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $13.00 ,the lowest forecast is $3.00. The average price target represents 469.11% Increase from the current price of $1.23.
        What do analysts say about Wave Life Sciences?
        Wave Life Sciences’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 5 Wall Streets Analysts.
          When is Wave Life Sciences’s upcoming earnings report date?
          Wave Life Sciences’s upcoming earnings report date is Aug 11, 2022 which is in 85 days.
            How were Wave Life Sciences’s earnings last quarter?
            Wave Life Sciences released its earnings results on May 12, 2022. The company reported -$0.62 earnings per share for the quarter, missing the consensus estimate of -$0.541 by -$0.079.
              Is Wave Life Sciences overvalued?
              According to Wall Street analysts Wave Life Sciences’s price is currently Undervalued.
                Does Wave Life Sciences pay dividends?
                Wave Life Sciences does not currently pay dividends.
                What is Wave Life Sciences’s EPS estimate?
                Wave Life Sciences’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Wave Life Sciences have?
                Wave Life Sciences has 61,250,000 shares outstanding.
                  What happened to Wave Life Sciences’s price movement after its last earnings report?
                  Wave Life Sciences reported an EPS of -$0.62 in its last earnings report, missing expectations of -$0.541. Following the earnings report the stock price went down -12.245%.
                    Which hedge fund is a major shareholder of Wave Life Sciences?
                    Among the largest hedge funds holding Wave Life Sciences’s share is RA Capital Management. It holds Wave Life Sciences’s shares valued at 16M.


                      Wave Life Sciences Stock Analysis

                      Smart Score
                      Price Target
                      ▲(469.11% Upside)
                      Moderate Buy
                      The Wave Life Sciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Wave Life Sciences

                      Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

                      Similar Stocks
                      Price & Change
                      Voyager Therapeutics
                      Ionis Pharmaceuticals
                      Astria Therapeutics
                      Alterity Therapeutics

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis